510(k) K940564
K940564 is an FDA 510(k) premarket notification submitted by Dako Diagnostics , Ltd. for the device "IDEIA(TM) CHLAMYDIA BLOCKING REAGENTS, MODIFICATION". The FDA issued a decision of Substantially Equivalent on January 11, 1996. The device falls under product code LJC (Enzyme Linked Immunoabsorbent Assay, (Chlamydiae Group)), a Class I device regulated under 21 CFR 866.3120. Dako Diagnostics , Ltd. has at least 5 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- January 11, 1996
- Date Received
- February 3, 1994
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Enzyme Linked Immunoabsorbent Assay, (Chlamydiae Group)
- Device Class
- Class I
- Regulation Number
- 866.3120
- Review Panel
- MI
- Submission Type